Literature DB >> 9724302

Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium.

D Weihrauch1, J Tessmer, D C Warltier, W M Chilian.   

Abstract

Our objective was to delineate the temporal sequence of mitogenic activity in myocardial interstitial fluid (IF) during enhancement of collateral growth. Collateral development in chronically instrumented dogs was induced by eight 2-min coronary occlusions/day for 21 days. Collateralization was assessed by measurement of blood flow in the region distal to a total coronary occlusion. Myocardial IF was obtained periodically from an intramyocardial catheter, and mitogenic activity was assessed by proliferative response of cultured endothelial cells (EC) and vascular smooth muscle cells (VSMC) to the IF. Three experiments were conducted to test that the mitogenic activity is induced by protein growth factors: 1) protein digestion of the myocardial IF with Pronase-coupled latex beads; 2) heat inactivation (boiling) of the IF; and 3) neutralization of the mitogenic activity with antibodies for basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF). Blood flow was reconstituted to baseline levels during occlusion after 3 wk of repetitive coronary occlusions. After initiation of occlusion the mitogenic activity of the myocardial IF on VSMC and EC increased up to days 12-14 and was reduced on days 19-23. Pronase treatment and heat inactivation blocked the mitogenic effect. Treatment with antibodies for bFGF and VEGF neutralized the proliferative response to the myocardial IF at specific times. bFGF antibody inhibited the mitogenic effect significantly on days 12-14. VEGF antibody neutralized the mitogenicity of the myocardial IF on day 7, days 12 and 13, and days 19 and 20 significantly. We conclude that myocardial IF harvested from ischemic myocardium is highly mitogenic up to 2 wk after initiation of repetitive coronary occlusions. After 3 wk of ischemia, the degree of mitogenic activity for VSMC and EC was decreased from peak levels. The antibodies could not neutralize the mitogenic effect of the myocardial IF during this time period. These results suggest that mitogens are expressed during various stages of collateral development in a time-dependent manner, that the mitogens are proteinaceous in nature, and that bFGF and VEGF are released into the myocardial IF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724302     DOI: 10.1152/ajpheart.1998.275.3.H969

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 2.  Coronary collateral growth--back to the future.

Authors:  William M Chilian; Marc S Penn; Yuh Fen Pung; Feng Dong; Maritza Mayorga; Vahagn Ohanyan; Suzanna Logan; Liya Yin
Journal:  J Mol Cell Cardiol       Date:  2011-12-19       Impact factor: 5.000

3.  Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.

Authors:  V Lakshminarayanan; M Lewallen; N G Frangogiannis; A J Evans; K E Wedin; L H Michael; M L Entman
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

4.  Inducible nitric oxide synthase inhibits oxygen consumption in collateral-dependent myocardium.

Authors:  Yingjie Chen; Ping Zhang; Jingxin Li; Xin Xu; Robert J Bache
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

5.  Myocardial interstitial fluid inhibits proliferation and cardiomyocyte differentiation in pluripotent embryonic stem cells.

Authors:  Jordan R Van Orman; Dorothee Weihrauch; David C Warltier; John Lough
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-24       Impact factor: 4.733

6.  Stimulation of coronary collateral growth by granulocyte stimulating factor: role of reactive oxygen species.

Authors:  Ana Catarina R Carrão; William M Chilian; June Yun; Christopher Kolz; Petra Rocic; Kerstin Lehmann; Jeroen P H M van den Wijngaard; Pepijn van Horssen; Jos A E Spaan; Vahagn Ohanyan; Yuh Fen Pung; Ivo Buschmann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-06-18       Impact factor: 8.311

7.  Expression Patterns of miRNA-423-5p in the Serum and Pericardial Fluid in Patients Undergoing Cardiac Surgery.

Authors:  Shoichi Miyamoto; Shunsuke Usami; Yasuhide Kuwabara; Takahiro Horie; Osamu Baba; Daihiko Hakuno; Yasuhiro Nakashima; Masataka Nishiga; Masayasu Izuhara; Tetsushi Nakao; Tomohiro Nishino; Yuya Ide; Fumiko Nakazeki; Jun Wang; Koji Ueyama; Takeshi Kimura; Koh Ono
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

8.  Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis.

Authors:  Cristina Beltrami; Marie Besnier; Saran Shantikumar; Andrew I U Shearn; Cha Rajakaruna; Abas Laftah; Fausto Sessa; Gaia Spinetti; Enrico Petretto; Gianni D Angelini; Costanza Emanueli
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

9.  Pigment Epithelium-Derived Factor Increases Native Collateral Blood Flow to Improve Cardiac Function and Induce Ventricular Remodeling After Acute Myocardial Infarction.

Authors:  Xiucheng Liu; Zhiwei Liu; Jiali Chen; Lidong Zhu; Hao Zhang; Xiaoyu Quan; Yanliang Yuan; Haoran Miao; Bing Huang; Hongyan Dong; Zhongming Zhang
Journal:  J Am Heart Assoc       Date:  2019-11-13       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.